Effective immune control of tumor growth is likely a result of Treg suppression coupled with expansion, infiltration, and activation of CD8+ Teffs, which have the capacity to kill tumor cells upon recognition of specific antigens by the T cell receptor (TCR). The gene discussed is CD8A; the disease is neoplasm.